JPWO2021236771A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021236771A5
JPWO2021236771A5 JP2022571280A JP2022571280A JPWO2021236771A5 JP WO2021236771 A5 JPWO2021236771 A5 JP WO2021236771A5 JP 2022571280 A JP2022571280 A JP 2022571280A JP 2022571280 A JP2022571280 A JP 2022571280A JP WO2021236771 A5 JPWO2021236771 A5 JP WO2021236771A5
Authority
JP
Japan
Prior art keywords
alkyl
nitrogen
membered
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022571280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527315A (ja
JP2023527315A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033159 external-priority patent/WO2021236771A1/en
Publication of JP2023527315A publication Critical patent/JP2023527315A/ja
Publication of JP2023527315A5 publication Critical patent/JP2023527315A5/ja
Publication of JPWO2021236771A5 publication Critical patent/JPWO2021236771A5/ja
Ceased legal-status Critical Current

Links

JP2022571280A 2020-05-22 2021-05-19 Pd-l1を標的とするための方法及び組成物 Ceased JP2023527315A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063028882P 2020-05-22 2020-05-22
US63/028,882 2020-05-22
US202163159075P 2021-03-10 2021-03-10
US63/159,075 2021-03-10
PCT/US2021/033159 WO2021236771A1 (en) 2020-05-22 2021-05-19 Methods and compositions for targeting pd-l1

Publications (3)

Publication Number Publication Date
JP2023527315A JP2023527315A (ja) 2023-06-28
JP2023527315A5 JP2023527315A5 (https=) 2024-05-27
JPWO2021236771A5 true JPWO2021236771A5 (https=) 2024-05-27

Family

ID=78708022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571280A Ceased JP2023527315A (ja) 2020-05-22 2021-05-19 Pd-l1を標的とするための方法及び組成物

Country Status (9)

Country Link
US (1) US11760764B2 (https=)
EP (1) EP4153567A4 (https=)
JP (1) JP2023527315A (https=)
KR (1) KR20230030056A (https=)
CN (1) CN115835907A (https=)
AU (1) AU2021275118A1 (https=)
CA (1) CA3182131A1 (https=)
TW (1) TW202208320A (https=)
WO (1) WO2021236771A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3182595A1 (en) * 2020-06-17 2021-12-23 Mingming Zhang Immunosuppressant, and preparation method therefor and use thereof
JP2023539463A (ja) 2020-08-17 2023-09-14 アリゴス セラピューティクス インコーポレイテッド Pd-l1を標的とするための方法及び組成物
BR112023026747A2 (pt) * 2021-06-18 2024-03-12 Aligos Therapeutics Inc Métodos e composições para direcionamento de pd-l1
EP4363408A1 (en) * 2021-07-02 2024-05-08 Ascletics Bioscience Co., Ltd. Heterocyclic compounds as immunomodulators of pd-l1 interactions
JP2024525589A (ja) 2021-07-09 2024-07-12 アリゴス セラピューティクス インコーポレイテッド 抗ウイルス化合物
JP7776616B2 (ja) * 2021-08-17 2025-11-26 アスカレシス バイオサイエンス カンパニー リミテッド Pd-l1相互作用の免疫調節剤としての化合物
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CA3240346A1 (en) 2021-12-16 2023-06-22 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
JP2025527595A (ja) * 2022-11-22 2025-08-22 西安新通薬物研究股▲フン▼有限公司 新規二環系pd-l1阻害剤、その製造方法、及び医薬使用
WO2025015063A1 (en) * 2023-07-13 2025-01-16 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025174835A1 (en) * 2024-02-15 2025-08-21 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199281A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199273A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359084A (en) 1993-02-18 1994-10-25 General Electric Company Method of preparing aromatic ether bisimides
US6638967B2 (en) 2000-08-08 2003-10-28 Ortho-Mcneil Phamraceutical, Inc. Thiophene of furan pyrrolidine compounds
DE10104279A1 (de) 2001-01-31 2002-08-01 Heinz Langhals Kompetitive Prionen-Reagenzien und ihre Anwendung in Diagnostik und Therapie
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
KR101462535B1 (ko) 2007-10-15 2014-11-19 삼성디스플레이 주식회사 인덴 유도체 화합물 및 이를 이용한 유기 발광 소자
WO2010065668A1 (en) 2008-12-03 2010-06-10 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
WO2010096777A1 (en) 2009-02-23 2010-08-26 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
CN102422449B (zh) 2009-05-11 2014-01-29 大日精化工业株式会社 有机半导体材料、有机半导体薄膜以及有机薄膜晶体管
JP5765229B2 (ja) 2009-10-05 2015-08-19 和光純薬工業株式会社 新規重水素化方法
WO2011082400A2 (en) 2010-01-04 2011-07-07 President And Fellows Of Harvard College Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
KR101832171B1 (ko) 2010-10-25 2018-04-16 삼성디스플레이 주식회사 축합환 화합물, 이를 포함한 유기 발광 소자 및 상기 유기 발광 소자를 포함한 평판 표시 장치
JP5728921B2 (ja) 2010-12-10 2015-06-03 コニカミノルタ株式会社 光学フィルム、及びそれを用いた偏光板、液晶表示装置
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
ITMI20110881A1 (it) 2011-05-18 2012-11-19 E T C Srl Materiale semiconduttore organico
JP6576955B2 (ja) 2014-02-20 2019-09-18 イノベーションラブ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングInnovationlab Gmbh 共役ポリマー
KR20160001537A (ko) 2014-06-27 2016-01-06 희성소재 (주) 피라졸계 화합물 및 이를 이용한 유기발광소자
WO2016046300A1 (en) 2014-09-24 2016-03-31 Solvay Specialty Polymers Italy S.P.A. Fluoropolymer composition
CN104478900B (zh) 2014-12-02 2017-05-31 国家纳米科学中心 一种内酰胺类受体单元及其制备方法和用途
AU2017305399A1 (en) 2016-08-03 2019-01-31 Arising International, Inc. Symmetric or semi-symmetric compounds useful as immunomodulators
KR20180063710A (ko) 2016-12-02 2018-06-12 (주)피엔에이치테크 유기발광 화합물 및 이를 포함하는 유기전계발광소자
WO2018119263A1 (en) * 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds derivatives as pd-l1 internalization inducers
ES2874756T3 (es) * 2016-12-22 2021-11-05 Incyte Corp Derivados de triazolo[1,5-A]piridina como inmunomoduladores
EP3558990B1 (en) * 2016-12-22 2022-08-10 Incyte Corporation Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
AU2017382870B2 (en) * 2016-12-22 2022-03-24 Incyte Corporation Benzooxazole derivatives as immunomodulators
EP3381906A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Compounds for use as heparanase inhibitors
BR102018007822A2 (pt) * 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
CN110869467B (zh) 2017-10-04 2022-05-10 株式会社艾迪科 组合物、固化物及固化物的制造方法
CN111094256A (zh) 2017-10-05 2020-05-01 株式会社艾迪科 化合物、潜在性紫外线吸收剂、组合物、固化物及固化物的制造方法
CN107721805A (zh) 2017-11-08 2018-02-23 长春海谱润斯科技有限公司 一种有机电致发光材料及其有机发光器件
KR102591947B1 (ko) * 2018-04-19 2023-10-25 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
CN111936532B (zh) 2018-05-08 2024-03-12 株式会社艾迪科 化合物、潜伏性添加剂、组合物、固化物、固化物的制造方法及组合物的制造方法
CN112424185B (zh) 2018-07-13 2024-05-17 广州丹康医药生物有限公司 含苯环的化合物、其制备方法及应用
CN111039942B (zh) 2018-10-12 2023-04-14 上海长森药业有限公司 含氮杂环类化合物,及其制备方法、药物组合物和应用
WO2020126970A1 (en) 2018-12-19 2020-06-25 Solvay Specialty Polymers Usa, Llc Method for manufacturing a three-dimensional object
DE102019200805A1 (de) 2019-01-23 2020-07-23 Henkel Ag & Co. Kgaa Neue fluoreszierende Materialien auf Basis von Phthalimiden
CN111574504A (zh) 2019-02-19 2020-08-25 江苏三月光电科技有限公司 一种基于氮杂苯和二甲酰二胺衍生物的有机化合物及其应用
US20220185785A1 (en) 2019-04-12 2022-06-16 TONIX Pharmaceuticals Holding Corp Inhibitors of cd40-cd154 binding
KR20220004100A (ko) 2019-04-18 2022-01-11 하이노바 파마슈티컬스 인코포레이티드 안드로겐 수용체를 표적 분해하는 이중 기능성의 키메라 헤테로 고리 화합물 및 이의 용도
SG11202112875UA (en) 2019-06-20 2021-12-30 Chemocentryx Inc Compounds for treatment of pd-l1 diseases
CN110746344A (zh) 2019-11-19 2020-02-04 上海天马有机发光显示技术有限公司 一种化合物及其应用
JP2023539463A (ja) 2020-08-17 2023-09-14 アリゴス セラピューティクス インコーポレイテッド Pd-l1を標的とするための方法及び組成物
BR112023026747A2 (pt) 2021-06-18 2024-03-12 Aligos Therapeutics Inc Métodos e composições para direcionamento de pd-l1

Similar Documents

Publication Publication Date Title
JPWO2021236771A5 (https=)
AU2016200538B2 (en) Compounds and their use as BACE inhibitors
JP2006507355A5 (https=)
JP6784348B2 (ja) Sting作動化合物
JP2025525938A (ja) Krasの阻害のための組成物及び方法
RU2378263C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
JP2005538100A5 (https=)
IL295569A (en) Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
JP6266659B2 (ja) 癌の治療のための安息香酸誘導体mdm2阻害剤
JP6171003B2 (ja) ピロロピロリジノン化合物
JPWO2020061101A5 (https=)
IL295930A (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
JP2001526269A5 (https=)
JP2019536779A5 (https=)
IL154350A (en) Phenylalanine derivatives and pharmaceutical preparations containing them
JP2011528034A5 (https=)
JP2005514398A5 (https=)
JP2013538802A5 (https=)
JP2003517010A5 (https=)
JP2010532386A5 (https=)
KR910009692A (ko) 인돌 유도체
ATE357142T1 (de) 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen
JP2003535128A5 (https=)
AR116474A1 (es) DERIVADOS DEL ÁCIDO 6,7-DIHIDRO-2H-BENZOFURO[2,3-a]QUINOLIZIN-3-CARBOXÍLICO COMO AGENTES ANTIVIRALES PARA EL TRATAMIENTO O PREVENCIÓN DE UNA INFECCIÓN POR HBV